AMN Healthcare Services Inc AMN
34.56
0.00
0.00%
as of 25 Sep
- Market cap
- $1.3B
- P/E
- 12.8×
Follow AMN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 11.99 |
P/S ratio |
0.28 | 0.22 | 0.21 | 0.37 | |
P/FCF ratio |
3.38 | 2.62 | 1.01 | 2.89 | |
P/Operating CF |
32.99 | 8.03 | 1.27 | (6.65) | |
P/B ratio |
1.16 | 0.95 | 1.00 | 1.70 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.57 | 0.49 | 0.26 | 0.48 | |
EV/EBITDA |
6.80 | 6.36 | 2.88 | 4.75 | |
EV/Operating CF |
5.78 | 4.97 | 1.21 | 3.49 | |
EV/FCF |
6.97 | 5.77 | 1.27 | 3.76 | |
Quick Ratio |
0.91 | 0.80 | 0.96 | 1.02 | |
Current Ratio |
1.05 | 0.94 | 1.09 | 1.13 | |
Net Debt/EBITDA |
9.10 | 16.17 | 1.19 | 6.25 | |
Debt/Assets |
39.59% | 36.63% | 28.51% | 31.43% | |
Debt/Equity |
1.31 | 1.19 | 1.04 | 1.00 | |
Asset Turnover |
1.13 | 1.21 | 1.37 | 1.50 | |
Operating CF/Net income |
0.77 | (9.82) | 9.05 | (8.98) | |
Capex/Depreciation |
(0.20) | (0.21) | (0.20) | (0.27) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
21.84% | 20.33% | 15.85% | 21.89% | |
Intangible Assets out of Total Assets |
0.49 | 0.50 | 0.39 | 0.43 | |
Share Based Compensation of Revenue |
1.06% | 0.77% | 0.72% | 1.46% | |
Graham Net Nets |
(1.24) | (1.49) | (1.06) | (0.60) | |
Graham Number |
0.00 | 0.00 | 0.00 | 33.97 | |
Earnings Yield |
(37.14%) | (15.80%) | (4.69%) | 8.34% | |
Free Cash Flow Yield |
29.57% | 38.24% | 98.76% | 34.59% | |
Revenue per Share |
16.43 | 19.42 | 35.43 | 17.25 | |
Operating CF per Share |
0.59 | 1.96 | 14.46 | (4.87) | |
Capex per Share |
(0.20) | (0.21) | (0.19) | (0.23) | |
Free Cash Flow per Share |
0.38 | 1.76 | 14.27 | (5.10) | |
Cash per Share |
1.36 | 0.88 | 14.41 | 9.27 | |
Shareholders Equity per Share |
16.69 | 16.67 | 18.32 | 19.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.69 | 16.67 | 18.32 | 19.00 | |
Free Cash Flow |
14.76 | 67.63 | 555.21 | (198.97) | |
Working Capital |
28.16 | (32.24) | 92.33 | 98.77 | |
Capital Expenditures |
(7.91) | (7.95) | (7.25) | (9.04) | |
Net Current Asset Value |
(924.22) | (906.62) | (755.05) | (753.44) | |
EV/EBIT |
0.00 | 0.00 | 18.20 | 8.23 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
4.62% | (1.03%) | 4.51% | 3.14% | |
Price to Operating Income |
0.00 | 0.00 | 14.50 | 6.32 | |
| Other line items | |||||
Average Receivables |
481.17 | 469.45 | 464.67 | 435.77 | |
Average Payables |
192.17 | 173.14 | 196.68 | 184.42 | |
Average Assets |
2,403.38 | 2,254.92 | 2,499.75 | 2,288.10 | |
Average Common Equity |
767.54 | 674.36 | 713.93 | 674.44 |
Columns are period end dates